Stocks / Biotech

IOVABiotech

Iovance Biotherapeutics, Inc.
$10.051d +0.6%5d +23.5%settled close · 2026-09-17
Mkt cap $1.5B (3/25)β 0.3552w $3.30–10.05Shares 412.0MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2010Emp. 975HQ San Carlos, CAiovance.com
Who’s talkingIdea Scout · free

Who’s talking about IOVA

No tracked investor commentary on IOVA yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 4 Nov 2026

Confirmed date · consensus EPS -0.10. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where IOVA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-17
2026-08-21
2026-08-20
2026-08-19
2026-08-06
2026-07-21
2026-07-16
2026-07-15
2026-05-27
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on IOVA is in this morning’s Brief. Get The Brief — $20/mo →